DE60232670D1 - Mutierte abl-kinase-domänen - Google Patents

Mutierte abl-kinase-domänen

Info

Publication number
DE60232670D1
DE60232670D1 DE60232670T DE60232670T DE60232670D1 DE 60232670 D1 DE60232670 D1 DE 60232670D1 DE 60232670 T DE60232670 T DE 60232670T DE 60232670 T DE60232670 T DE 60232670T DE 60232670 D1 DE60232670 D1 DE 60232670D1
Authority
DE
Germany
Prior art keywords
polypeptides
amino acid
nucleic acid
acid molecules
tyrosine kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232670T
Other languages
English (en)
Inventor
Christophe Barthe
Susan Branford
Amie Corbin
Brian Jay Druker
Justus Duyster
Andreas Hochhaus
Timothy Hughes
Sebastian Kreil
Thibaut Leguay
Francois-Xavier Mahon
Gerald Marit
Martin Mueller
Christian Peschel
Claude Preudhomme
Lestienne Catherine Roche
Zbigniew Rudzki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Novartis AG
Universitaet Heidelberg
Technische Universitaet Muenchen
Universite Victor Segalen Bordeaux 2
Centre Hospitalier Universitaire de Lille CHU
Oregon Health Science University
Original Assignee
Medvet Science Pty Ltd
Novartis AG
Universitaet Heidelberg
Technische Universitaet Muenchen
Universite Victor Segalen Bordeaux 2
Centre Hospitalier Regional Universitaire de Lille CHRU
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd, Novartis AG, Universitaet Heidelberg, Technische Universitaet Muenchen, Universite Victor Segalen Bordeaux 2, Centre Hospitalier Regional Universitaire de Lille CHRU, Oregon Health Science University filed Critical Medvet Science Pty Ltd
Application granted granted Critical
Publication of DE60232670D1 publication Critical patent/DE60232670D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60232670T 2001-10-05 2002-10-04 Mutierte abl-kinase-domänen Expired - Lifetime DE60232670D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32738901P 2001-10-05 2001-10-05
US32874001P 2001-10-12 2001-10-12
US34735102P 2002-01-11 2002-01-11
PCT/EP2002/011144 WO2003031608A2 (en) 2001-10-05 2002-10-04 Mutated abl kinase domains

Publications (1)

Publication Number Publication Date
DE60232670D1 true DE60232670D1 (de) 2009-07-30

Family

ID=27406519

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60232670T Expired - Lifetime DE60232670D1 (de) 2001-10-05 2002-10-04 Mutierte abl-kinase-domänen
DE60238511T Expired - Lifetime DE60238511D1 (de) 2001-10-05 2002-10-04 Mutante der kinase Domäne des ABL

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60238511T Expired - Lifetime DE60238511D1 (de) 2001-10-05 2002-10-04 Mutante der kinase Domäne des ABL

Country Status (7)

Country Link
US (4) US20050202519A1 (de)
EP (8) EP2341133A1 (de)
JP (2) JP4243191B2 (de)
AT (2) ATE434038T1 (de)
DE (2) DE60232670D1 (de)
PT (1) PT2017335E (de)
WO (1) WO2003031608A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2753372C (en) * 2001-06-14 2018-08-07 The Regents Of The University Of California Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
GB0201384D0 (en) * 2002-01-22 2002-03-13 European Molecular Biology Lab Embl Tyrosine kinase inhibitors
US20050148605A1 (en) 2003-11-13 2005-07-07 Ambit Biosciences Corporation Amide derivatives as ABL modulators
CN103356636A (zh) 2004-05-23 2013-10-23 杰勒德·M·豪斯 Theramutein调节剂
WO2007014250A2 (en) * 2005-07-26 2007-02-01 Vertex Pharmaceuticals Incorporated Abl kinase inhibition
WO2007058991A2 (en) * 2005-11-14 2007-05-24 Novartis Ag Mutations and polymorphisms of c-abl
WO2007062213A2 (en) 2005-11-23 2007-05-31 Housey Pharmaceuticals Inc Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
EP3002009B1 (de) 2007-06-01 2021-07-07 Wyeth LLC Behandlung von imatinib-resistenter chronischer myelogener leukämie mit der mutation 1457t>c im bcrabl gen unter verwendung der verbindung bosutinib
US9232968B2 (en) 2007-12-19 2016-01-12 DePuy Synthes Products, Inc. Polymeric pedicle rods and methods of manufacturing
US8586310B2 (en) 2008-09-05 2013-11-19 Washington University Method for multiplexed nucleic acid patch polymerase chain reaction
US11111514B2 (en) 2008-09-05 2021-09-07 Washington University Method for multiplexed nucleic acid patch polymerase chain reaction
US9909170B2 (en) 2008-09-05 2018-03-06 Washington University Method for multiplexed nucleic acid patch polymerase chain reaction
US9702877B2 (en) * 2008-10-31 2017-07-11 Quest Diagnostics Investments Incorporated BCR-ABL variants
US8641734B2 (en) 2009-02-13 2014-02-04 DePuy Synthes Products, LLC Dual spring posterior dynamic stabilization device with elongation limiting elastomers
US9320543B2 (en) 2009-06-25 2016-04-26 DePuy Synthes Products, Inc. Posterior dynamic stabilization device having a mobile anchor
US9488656B2 (en) 2009-09-30 2016-11-08 Quest Diagnostics Investments Incorporated BCR-ABL truncation mutations
JP5359924B2 (ja) * 2010-02-18 2013-12-04 株式会社島津製作所 質量分析装置
US9445844B2 (en) 2010-03-24 2016-09-20 DePuy Synthes Products, Inc. Composite material posterior dynamic stabilization spring rod
US8603740B2 (en) 2010-12-29 2013-12-10 Quest Diagnostics Investments Incorporated BCR-ABL1 splice variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (de) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
CA2753372C (en) * 2001-06-14 2018-08-07 The Regents Of The University Of California Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
US20030170851A1 (en) * 2001-10-05 2003-09-11 Christophe Barthe Organic compounds

Also Published As

Publication number Publication date
EP2343367A1 (de) 2011-07-13
ATE490308T1 (de) 2010-12-15
EP1436384B1 (de) 2009-06-17
EP2343366A1 (de) 2011-07-13
US20050202519A1 (en) 2005-09-15
WO2003031608A3 (en) 2003-12-18
EP2290056A3 (de) 2011-06-01
DE60238511D1 (de) 2011-01-13
EP2341133A1 (de) 2011-07-06
ATE434038T1 (de) 2009-07-15
JP2005504549A (ja) 2005-02-17
EP2017335A1 (de) 2009-01-21
PT2017335E (pt) 2011-03-02
EP2246416A1 (de) 2010-11-03
EP2343365A1 (de) 2011-07-13
US20090117641A1 (en) 2009-05-07
EP2017335B1 (de) 2010-12-01
JP4243191B2 (ja) 2009-03-25
WO2003031608A2 (en) 2003-04-17
US20100021920A1 (en) 2010-01-28
US20100021921A1 (en) 2010-01-28
EP2290056A2 (de) 2011-03-02
JP2009165464A (ja) 2009-07-30
EP1436384A2 (de) 2004-07-14

Similar Documents

Publication Publication Date Title
DE60232670D1 (de) Mutierte abl-kinase-domänen
Wu et al. The Drosophila zeste gene and transvection
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
DK1392359T3 (da) Specifikke bindingsproteiner og deres anvendelser
DE60335794D1 (de) Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
DK0737207T3 (da) Inhibitorer for humant plasmin afledt af Kunitz-domæner
ATE398676T2 (de) Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins
FI934811A (fi) Stabiliserade enzymer och detergentfoereningar
RS50728B (sr) Nukleinske kiseline i polipeptidi novog receptora
CA2256483A1 (en) P13 lipid kinase
WO2001055207A8 (en) Nucleic acids, proteins, and antibodies
BR0315327A (pt) Antagonistas de il-15
CY1109518T1 (el) Αναστολεας ενεργοποιητη αυξητικου παραγοντα ηπατοκυτταρων για χρηση σε διαμορφωση αγγειογενεσης και καρδιοαγγειωσης
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
EP1279744A3 (de) Identifizierung und Verwendung von Molekülen, die mit Schmerzempfinden impliziert sind
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
ATE340257T1 (de) Histonedeacetylase 9
EA200601749A1 (ru) Коспептин, космедин и варианты их применения
NO980122L (no) Emaljematriksrelatert polypeptid
DK1863834T3 (da) Polypeptider og nukleinsyrer, der koder disse
ATE513906T1 (de) Galactosyltransferase
WO2005079316A3 (en) Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
DE60225699D1 (de) Nierenspezifischer urattransporter und dessen gen
ATE374819T1 (de) Antagonistischer antikörper gegen pro842

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN